There are many pharmaceutical treatment interventions that have been used or are currently under review for Alopecia Areata, Totalis, and Universalis. We try to as close to the facts as possible concerning pharmaceutical treatment approaches.
Cure of alopecia areata after eradication of Helicobacter pylori: A new association? Alopecia areata is a disease of the hair follicles, with strong evidence supporting autoimmune etiology. Alopecia areata is frequently…Cure of alopecia areata after eradication of Helicobacter pylori: A new association? … Continue reading
By Rob Swierski We’re all aware of the various ways which we, and our healthcare providers, have approached treating Alopecia Areata. Medical applications including topical corticosteroids and intralesional corticosteroid injections…By Rob Swierski We’re all aware of the various ways which … Continue reading
Some studies have hypothesized that filaggrin gene mutations (FLG) may play a role in AA, particularly in patients with multiple (comorbid) atopic diseases. Filaggrin is a protein that binds to…Some studies have hypothesized that filaggrin gene mutations (FLG) may play … Continue reading
via Jan Bowers, Dermatology World Alopecia areata (AA) presents a thorny challenge to dermatologists searching for an effective treatment. It can resolve spontaneously with no intervention. There are no treatments approved…via Jan Bowers, Dermatology World Alopecia areata (AA) presents a thorny challenge … Continue reading
August 23rd, 2011Posted in Health News Vitamin D has been a recognized autoimmune-fighting tool for some time, but no one was sure exactly how it worked. Now we do. Research published…August 23rd, 2011Posted in Health News Vitamin D has been a recognized … Continue reading
NAAF has recently posted an announcement seeking children trial participants (ages 5-17) for an Eyelash Growth Study for the drug Bimatoprost…complete with a sweet picture of a young child with…NAAF has recently posted an announcement seeking children trial participants (ages … Continue reading
Clin Ophthalmol. 2011;5:759-65. Epub 2011 Jun 7. Wirta D, Vandenburgh AM, Weng E, Whitcup SM, Kurstjens S, Beddingfield FC 3rd. Source Private Practice, Newport Beach, CA, USA. wirta1@hotmail.com Abstract BACKGROUND: Bimatoprost ophthalmic solution 0.03% was approved…Clin Ophthalmol. 2011;5:759-65. Epub 2011 Jun 7. Wirta D, Vandenburgh AM, Weng E, Whitcup SM, Kurstjens … Continue reading
